Posted in | News | Plastics and Polymers

New Specialty Monomer from BASF

BASF, one of the world’s leading chemical companies, has introduced a new specialty monomer, hydroxypropyl carbamate acrylate (HPCA). It is a crosslinking acrylate monomer, which reduces the manufacturing process of carbamate-based polymers.

The HPCA has been successfully utilized in clearcoat systems in the automotive industry. It enables one-component coatings instead of two-component coatings. One-component coatings offer high performance in terms of weather and scratch resistance when compared to two-component coatings. In addition, application of one-component coatings is easy and cost-effective.

The HPCA has a unique chemical structure with free carbamate group. The specialty monomer has extra potential for an extensive range of applications in the future. BASF has planned to work with its customers to devise new application areas such as adhesives. The HPCA’s special structure can impact the cohesion and adhesion properties in a positive way.

Researchers from BASF have used a white biotechnology process to manufacture HPCA specialty monomers on a commercial scale. The carbamate-based polyacrylate can later be produced from HPCA. The company has used the biocatalytic procedure for the first time in industrial production.

Source: http://www.basf.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BASF Corporation. (2019, February 09). New Specialty Monomer from BASF. AZoM. Retrieved on May 06, 2024 from https://www.azom.com/news.aspx?newsID=29922.

  • MLA

    BASF Corporation. "New Specialty Monomer from BASF". AZoM. 06 May 2024. <https://www.azom.com/news.aspx?newsID=29922>.

  • Chicago

    BASF Corporation. "New Specialty Monomer from BASF". AZoM. https://www.azom.com/news.aspx?newsID=29922. (accessed May 06, 2024).

  • Harvard

    BASF Corporation. 2019. New Specialty Monomer from BASF. AZoM, viewed 06 May 2024, https://www.azom.com/news.aspx?newsID=29922.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.